乳糜性腹水诊治现状*

doi:10.3969/j.issn.1672-5069.2018.05.003

实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (5): 665-668.doi: 10.3969/j.issn.1672-5069.2018.05.003

乳糜性腹水诊治现状^*

李越, 丁惠国

100069 北京市首都医科大学附属北京佑安医院肝病消化中心

收稿日期:2018-06-20 出版日期:2018-09-10 发布日期:2018-09-27
通讯作者: 丁惠国, E-mail:dinghuiguo@ccmu.edu.cn
作者简介:李越，女，28岁，消化内科学博士研究生。E-mail:liyue524@qq.com
基金资助:
北京市医院管理局扬帆计划项目（编号：ZYLX201610）; 登峰计划项目（编号：DFL20151602）

Current diagnosis and treatment of chylous ascites

Li Yue, Ding Huiguo.

Department of Gastroenterology and Hepatology,You’an Hospital Affiliated to Capital Medical University,Beijing 100069

Received:2018-06-20 Online:2018-09-10 Published:2018-09-27

摘要/Abstract

关键词: 乳糜性腹水, 发病机制, 病因, 诊断, 治疗

Key words: Chylous ascites, Pathogenesis, Etiologies, Diagnose, Treatment

李越, 丁惠国. 乳糜性腹水诊治现状^*[J]. 实用肝脏病杂志, 2018, 21(5): 665-668.

Li Yue, Ding Huiguo.. Current diagnosis and treatment of chylous ascites[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 665-668.

[1] Lizaola B,Bonder A,Trivedi HD,et al.The diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther 2017,46(9):816-824.
[2] Mukherjee A,Sehgal IS,Mittal BR,et al. Transudative chylothorax:an uncommon illness due to a common cause. BMJ Case Rep,2018[ahead of print].
[3] Doerr CH,Allen MS,Nichols FC III,et al.Etiology of chylothorax in 203 patients. Mayo Clin Proc,2005,80:867-870.[4] Browse NL,Wilson NM,Russo F,et al. Aetiology and treatment of chylous ascites. Br J Surg,1992,79:1145-1150.
[5] Ur Rahman A,Ramaraj R,Humphreys E,et al.Retroperitoneal fibrosis as a cause of chylous ascites. ACG Case Rep J,2017,4:e115.
[6] Talluri SK,Nuthakki H,Tadakamalla A,et al.Chylous ascites. N Am J Med Sci,2011,3(9):438-440.
[7] Steinemann DC,Dindo D,Clavien PA,et al.Atraumatic chylous ascites:systematic review on symptoms and causes. J Am Coll Surg,2011,212:899-905.
[8] Yau KK,Siu WT,Li MK.Chylous ascites in a patient with esophageal carcinoma. Clin Gastroenterol Hepatol,2005,3:A33.
[9] Runyon BA,Hoefs JC,Morgan TR.Ascitic fluid analysis in malignancy-related ascites. Hepatology,1988,8:1104-1109.
[10] Romero S,Martin C,Hernandez L,et al.Chylothorax in cirrhosis of the liver:analysis of its frequency and clinical characteristics. Chest,1998,114:154-159.
[11] Rabie H,Lomp A,Goussard P,et al.Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child. J Trop Pediatr,2010,56(5):355-358.
[12] Vignes S,Bellanger J.Primary intestinal lymphangiectasia (Waldmann’s disease). Orphanet J Rare Dis,2008,3:5.
[13] Duhra PM,Quigley EM,Marsh MN.Chylous ascites,intestinal lymphangiectasia and the‘yellow-nail’ syndrome. Gut,1985,26:1266-1269.
[14] Scribner DR Jr,Lara-Torre E,Heineck RJ,et al.Klippel-Trenaunay syndrome complicated by ascites and vaginal lymphatic drainage in adolescence:a case report. J Pediatr Adolesc Gynecol,2012,25:e139-e141.
[15] Nerune SM,Arakeri SU,Patil VL,et al. Bilateral cystic lymphangioma of ovary associated with chylous ascites. J Clin Diagn Res,2015,9(8):ED18-19.
[16] Lee CK,Han JM,Lee KN,et al.Concurrent occurrence of chylothorax,chylous ascites,and protein-losing enteropathy in systemic lupus erythematosus. J Rheumatol,2002,29:1330-1333.
[17] Chen GL,Yang DH,Hsu WH.Chylous ascites and pleural transudate:rare presentations in systemic lupus erythematosus in old age. Case Rep Immunol,2012,2012:390831.
[18] Williams AM,Seay TM,Hundley JC,et al.Direct intranodal lymphangiography for recurrent chylous ascites following liver-kidney transplantation. Liver Transpl,2014,20:1275-1276.
[19] Yilmaz M,Akbulut S,Isik B,et al.Chylous ascites after liver transplantation:incidence and risk factors. Liver Transpl,2012,18:1046-1052.
[20] Muela Molinero A,Borrego Galan JC,Quiroga Prado L.Chylous ascites secondary to Whipple disease. Rev Clin Esp,2011,211:e28-e29.
[21] Lippey JF,Yong TL.Chyle leak following biliary pancreatitis. J Surg Case Rep,2014,2014.
[22] Lin WY,Lin GM,Wu CC.Coexistence of non-communicated chylothorax and chylous ascites in nephrotic syndrome. Nephrology,2009,14:700.
[23] Andraus W,Nacif LS,Araujo RL,et al.Chronic pancreatitis associated with chylous ascites simulating liver cirrhosis. Case Rep Surg,2013,2013:763561.
[24] Santos MA,Bose PS,Maher S,et al. Chylous ascites:an unusual complication of necrotizing pancreatitis. Am J Med,2017,130:e151e152.
[25] Cardenas A,Chopra S.Chylous ascites. Am J Gastroenterol, 2002,97:1896-1900.
[26] Chakraborty S,Davis MJ,Muthuchamy M.Emerging trends in the pathophysiology of lymphatic contractile function. Semin Cell Dev Biol,2015,38:55-66.
[27] Tao L,Ning HJ,Nie HM,et al.Diagnostic value of adenosine deaminase in ascites for tuberculosis ascites:a meta-analysis. Diagn Microbiol Infect Dis,2014,79:102-107.
[28] Khandwalla HE,Fasakin Y,El-Serag HB.The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol,2009,104:1401-1405.
[29] Bhardwaj R,Vaziri H,Gautam A,et al.Chylous ascites:A review of pathogenesis,diagnosis and treatment. J Clin Transl Hepatol,2018,6(1):105-113.
[30] Al-Busafi SA,Ghali P,Deschênes M,et al.Chylous ascites: Evaluation and management. ISRN Hepatol,2014,2014:240473.
[31] Zhou DX,Zhou HB,Wang Q,et al.The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis. Dig Dis Sci,2009,54:1783-1788.
[32] Nunes G,Fonseca C,Barosa R,et al.Idiopathic chylous ascites in a patient with HIV infection:response to total parenteral nutrition and octreotide therapy. Clin J Gastroenterol,2018,11(3):235-239.
[33] 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南.实用肝脏病杂志,2018,21(1):21-31.
[34] Tsauo J,Shin JH,Han K,et al.Transjugular intrahepatic portosystemic shunt for the treatment of chylothorax and chylous ascites in cirrhosis:a case report and systematic review of the literature. J Vasc Interv Radiol,2016,27:112-116.
[35] Weniger M,D’Haese JG,Angele MK,et al. Treatment options for chylous ascites after major abdominal surgery:a systematic review. Am J Surg,2016,211:206-213.
[36] Pamarthi V,Stecker MS,Schenker MP,et al.Thoracic duct embolization and disruption for treatment of chylous effusions:experience with 105 patients. J Vasc Interv Radiol,2014,25:1398-1404.
[37] Kim J,Won JH.Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol,2016,19(4):291-298.
[38] Nadolski GJ,Chauhan NR,Itkin M.Lymphangiography and lymphatic embolization for the treatment of refractory chylous ascites. Cardiovasc Intervent Radiol,2018,41(3):415-423.

乳糜性腹水诊治现状^*

Current diagnosis and treatment of chylous ascites

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈帅, 杨长青. 门静脉血栓病因及危险因素研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 761-764.
[2]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[3]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[4]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[5]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[6]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[7]	潘美民, 李文娟, 蒋芳清, 杨丽晖, 谭永卫, 何娟, 阮建文, 蔡春琳. 慢性丙型肝炎患者血清IL-17A、FGF和IL-7水平与丙型肝炎病毒感染自发清除临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 840-843.
[8]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[9]	丁利敏, 王飞, 朴莲淑, 张孟, 刘城, 李芊蔚, 徐德魁, 于庆功. 202例肝功能异常患者病因分析[J]. 实用肝脏病杂志, 2019, 22(6): 856-859.
[10]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[11]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[12]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[13]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[14]	曾艳妮, 张灿, 毕俊英, 刘良进, 孟俊, 秦涛. MRI长时间延迟增强扫描诊断肝脏孤立性坏死性结节价值研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 900-903.
[15]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.